| Strategy/Fund | Net Asset Value ($ millions) |
| Common Investment Fund | 4,357.5 |
| Global Equities | 1,243.1 |
| BNY DUSE | 287.0 |
| BNY Stock Index | 146.5 |
| DSM | 322.3 |
| Gardner Russo | 78.1 |
| GMO | 357.6 |
| Kabouter | 51.5 |
| Emerging Markets Equities | 57.0 |
| Acadian | 57.0 |
| Fixed Income | 454.4 |
| GSAM - FI Core | 63.1 |
| Internal Cash | 391.3 |
| Hedge Funds | 729.2 |
| Anchorage | 28.0 |
| BlackRock Emerging Companies | 50.3 |
| BlackRock Strategic | 96.3 |
| BlackRock Systematic China Absolute Return | 49.5 |
| Camber | 17.0 |
| Drake Funds | 94.1 |
| Elliott Intl | 72.5 |
| Indaba | 32.4 |
| Oculus Intn | 7.0 |
| Other | 7.6 |
| Samlyn Net Neutral | 72.3 |
| TAL China | 21.0 |
| The Obsidian Offshore | 50.0 |
| Two Sigma AR Enhanced | 27.4 |
| Viking | 103.8 |
| Private Investments | 1,676.9 |
| ABRY Adv Sec II | .2 |
| ABRY Adv Sec III | 9.6 |
| ABRY SR Eq. V | 5.3 |
| ABRY Sr. Eq. IV | .9 |
| ABRY VII | 1.0 |
| ABRY VIII | 1.2 |
| Advent Intl IX | 31.0 |
| Advent Intl VII | 3.3 |
| Advent Intl VIII | 21.4 |
| Alkali International IV | 25.4 |
| Alkali International V | 6.2 |
| American Sec. VII | 19.5 |
| Arboretum IV | 6.7 |
| Artiman 2014 | 13.8 |
| Artiman III | 2.5 |
| Artiman Select 2014 | 2.1 |
| ASF VI | 4.0 |
| ASF VII | 16.8 |
| Atlas Capital II | 11.2 |
| Axiom Asia III | 8.9 |
| Axiom Asia IV | 45.5 |
| Axiom Asia Opportunity | .2 |
| Axiom Asia V | 19.2 |
| Axiom Asia VI | 5.5 |
| Bain X | 3.3 |
| Blackstone V | .1 |
| Blue Point IV | 19.0 |
| Brazos III | .5 |
| BSCH II | 6.8 |
| CA Bain Europe III | .5 |
| Castlelake IV | 11.3 |
| CB Offshore Equity Fund X. LP | 3.5 |
| Centerbridge Capital | .4 |
| Cerberus 4 | .1 |
| CF Intl PE V | .7 |
| CF Venture V | .3 |
| CF Venture VI | .6 |
| CF Venture VII | 1.8 |
| Charlesbank IX | 17.1 |
| Charlesbank VII | 1.0 |
| Charlesbank VIII | 4.2 |
| Columbia IV | 1.2 |
| Deerfield Design III | 12.5 |
| Deerfield Design IV | 31.2 |
| Dover IX | 20.4 |
| Dover VII | .2 |
| Dover VIII | 2.0 |
| Elliott B-1 L.P. | 26.5 |
| Flagship Pioneering Fund VII | 4.2 |
| Flagship Special Opportunities Fund II | 15.8 |
| Fortress Credit Opp III | 1.3 |
| Fortress Credit Opp IV | 10.3 |
| Fortress Credit Opp V | 11.7 |
| Foundation Capital Leadership II | 15.1 |
| Foundation Capital Leadership III | 3.1 |
| Foundation IX | 16.7 |
| Foundation VIII | 144.2 |
| Foundation X | 2.2 |
| Francisco II | .7 |
| Francisco III | 2.0 |
| Francisco IV | 17.5 |
| GGV IV | 4.4 |
| GGV Select | 17.8 |
| GGV V | 26.9 |
| GGV VI | 22.3 |
| GGV VI Plus | 9.8 |
| Granite II | 11.5 |
| Great Hill IV | 3.8 |
| Great Hill V | 8.9 |
| Great Hill VII | 6.4 |
| GTCR XI A | 32.5 |
| InterWest X | 9.8 |
| J.H. Whitney VII | 3.4 |
| JMI VI | .2 |
| JMI VII | .5 |
| JMI VIII | 10.9 |
| Kelso VIII | .8 |
| Lightspeed IX | 36.5 |
| Lightspeed Select | 17.3 |
| Lightspeed Select II | 18.0 |
| Lightspeed X | 31.5 |
| Lightspeed XI | 21.5 |
| Littlejohn Fund V | 13.1 |
| Littlejohn Opportunities II | 29.2 |
| Madison Dearborn V | .2 |
| Mangrove II | 2.5 |
| Meritech IV | 1.6 |
| Meritech V | 31.4 |
| Meritech V Sidecar | 20.0 |
| Meritech VI | 15.6 |
| Multi-Alt Opps | 14.7 |
| Olympus VI | 12.3 |
| Olympus VII | 17.6 |
| Operator Collective | 12.2 |
| Operator Collective II | .7 |
| OrbiMed Asia IV | 6.3 |
| OrbiMed Royalty II | 1.2 |
| OrbiMed V | 5.4 |
| OrbiMed VI | 15.1 |
| OrbiMed VII | 34.5 |
| OrbiMed VIII | 7.6 |
| Park St PE VII | .2 |
| Providence VI | .5 |
| Quibi Holdings (NewTV) | 3.3 |
| Rho VI | 5.9 |
| Sentinel V | 2.8 |
| Sigma IX | 8.3 |
| Strategic IX | 7.3 |
| Strategic VI | 6.7 |
| Strategic VII | 26.8 |
| Strategic VIII | 46.2 |
| SV Life Sciences V | 2.5 |
| SV Life Sciences VI | 12.9 |
| Symmetric | .8 |
| TA XI | 3.8 |
| TA XII-A | 31.2 |
| TA XIII-B | 16.9 |
| TA XIV-B | 5.3 |
| Telegraph Hill III | 10.1 |
| Thoma Bravo Discover | 3.4 |
| Thoma Bravo Sp Opp II | 3.8 |
| Thoma Bravo X | 4.4 |
| Thoma Bravo XI | 21.0 |
| Thoma Bravo XII | 26.4 |
| Thompson St IV | 21.4 |
| Thompson St V | 19.2 |
| Trident VI | 11.3 |
| Trident VII | 40.7 |
| TrueBridge | 41.3 |
| Truebridge II | 18.2 |
| Two Sigma III | 9.3 |
| U.S.V.P. X | 2.2 |
| Upfront Growth II | 8.8 |
| Upfront Growth III | 3.7 |
| Upfront VI | 17.9 |
| Upfront VII | 1.8 |
| Varde X | .3 |
| VIP II B | 16.9 |
| VIP II B SF | 2.1 |
| WndrCo | 4.6 |
| Private Real Assets | 121.2 |
| ArcLight Energy VI | 10.1 |
| Denham Commodity VI | 3.6 |
| Denham Oil & Gas | 9.4 |
| EnCap Flatrock Midst II | .8 |
| EnCap Flatrock Midst III | 6.9 |
| EnCap Flatrock Midst IV | 2.6 |
| EnCap IX | 3.6 |
| EnCap VII | .2 |
| EnCap VIII | 2.0 |
| EnCap X | 14.9 |
| EnerVest XIV | 11.2 |
| First Reserve XII | .4 |
| Lime Rock Partners IV AF, L.P. | 26.1 |
| Lime Rock Res. III-C | 6.0 |
| Lime Rock V | .6 |
| LS Power III | 14.6 |
| Park St NRF II | .1 |
| Resource Capital IV | .8 |
| Resource Capital V | .2 |
| Resource Capital VI | 6.9 |
| Private Real Estate | 75.7 |
| Blackstone RE Europe V | 16.2 |
| Blackstone RE IX | 19.7 |
| Blackstone RE VI | .2 |
| Blackstone RE VII | 2.6 |
| Blackstone RE VIII | 13.9 |
| Contrarian RE Debt II | .1 |
| CrossHarbor 2014 | 1.3 |
| Lone Star RE III | .1 |
| Lone Star RE IV | 3.4 |
| Lone Star RE V | 1.8 |
| Orion III | .7 |
| Orion IV | 2.2 |
| SSC IV | .8 |
| SSC V | 5.9 |
| Westbrook RE IX | 1.1 |
| Westbrook RE X | 5.8 |